Flow cytometric analysis of Human CD200 expression on human PBMC (human peripheral blood mononuclear cells). Human PBMC were stained with Brilliant Violet 421™ Mouse Anti-Human CD19 Antibody and either FITC Mouse IgG1, κ Isotype Control (Left panel) or SDT FITC Mouse Anti-Human CD200 Antibody (Right panel) at 5μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
Product Details
Product Details
Product Specification
Host | Mouse |
Antigen | CD200 |
Synonyms | OX-2 membrane glycoprotein; MOX1; MOX2 |
Location | Cell membrane |
Accession | P41217 |
Clone Number | S-R582 |
Antibody Type | Mouse mAb |
Isotype | IgG1,k |
Application | FCM |
Reactivity | Hu |
Positive Sample | human PBMC |
Purification | Protein G |
Concentration | 0.2 mg/ml |
Conjugation | FITC |
Physical Appearance | Liquid |
Storage Buffer | PBS, 25% Glycerol, 1% BSA, 0.3% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied. |
Dilution
application | dilution | species |
FCM | 5μl per million cells in 100μl volume | Hu |
Background
CD200, also known as OX-2, is a type I membrane glycoprotein belonging to the immunoglobulin superfamily. It is widely expressed on various cell types, including B cells, T cells, dendritic cells, neurons, and endothelial cells. CD200 primarily functions through its interaction with CD200R, a receptor expressed on myeloid cells, T cells, and other immune cells. This interaction suppresses T-cell-mediated immune responses, reduces the production of inflammatory cytokines, and promotes immune tolerance. In the context of cancer, CD200 expression on tumor cells can lead to immune evasion by inhibiting antitumor T-cell responses. Additionally, CD200 plays a crucial role in maintaining immune homeostasis and is involved in various autoimmune and inflammatory diseases.
Picture
Picture
FC
